05/09/2024
3:51 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/09/2024
3:06 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:08 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
5:05 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form DEF 14A | |
04/26/2024
5:10 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form DEFA14A | |
04/26/2024
5:14 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form ARS | |
04/16/2024
7:00 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form PRE 14A | |
|
04/04/2024
7:38 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:40 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
04/04/2024
7:15 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B5 | |
04/02/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
03/29/2024
1:51 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form POS AM | |
03/28/2024
3:02 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2024
7:57 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
3:10 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
4:39 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:20 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:22 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:25 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
4:27 PM | Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:48 PM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:48 AM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:14 PM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
01/30/2024
7:31 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
7:01 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
7:06 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
01/08/2024
7:19 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
01/08/2024
7:15 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:23 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:23 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:31 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
12/08/2023
7:31 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/29/2023
4:07 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
George Simeon (Reporting)
SR One Capital Fund I Aggregator LP (Reporting)
SR ONE CAPITAL MANAGEMENT, LLC (Reporting)
SR ONE CAPITAL PARTNERS I, LP (Reporting)
SR One Co-Invest I Manager, LLC (Reporting)
SR One Co-Invest I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
7:15 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
7:18 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/22/2023
3:16 PM | COLUMN GROUP II, LP (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
11/16/2023
4:30 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
4:26 PM | Byrnes Michael (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
3:33 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/13/2023
3:23 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:25 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Gold Set to EXPLODE! (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
09/15/2023
3:05 PM | COLUMN GROUP II, LP (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
09/11/2023
6:36 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2023
6:38 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:58 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
09/11/2023
3:51 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
3:16 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
08/14/2023
7:00 AM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
06/22/2023
7:10 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Gallagher Brian M. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:12 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:14 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:16 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:04 PM | Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:09 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
5:06 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
5:10 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
06/16/2023
3:53 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/08/2023
5:06 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B5 | |
06/08/2023
5:11 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
5:14 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/30/2023
3:29 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/30/2023
3:18 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B5 | |
05/25/2023
4:01 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
4:06 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/19/2023
4:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2023
4:20 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/16/2023
7:01 AM | Byrnes Michael (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:03 AM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
3:17 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form DEFA14A | |
